BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
1.430
-0.050 (-3.36%)
Nov 21, 2024, 11:54 AM EST - Market open
BioAtla Market Cap
BioAtla has a market cap or net worth of $69.14 million as of November 21, 2024. Its market cap has decreased by -18.04% in one year.
Market Cap
69.14M
Enterprise Value
16.29M
1-Year Change
-18.04%
Ranking
Category
Stock Price
$1.43
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $69.14M, a decrease of -88.03%. That is a compound annual growth rate of -41.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 71.55M | -39.32% |
| Dec 29, 2023 | 117.92M | -69.81% |
| Dec 30, 2022 | 390.66M | -45.97% |
| Dec 31, 2021 | 723.09M | -36.84% |
| Dec 31, 2020 | 1.14B | 98.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Renovaro | 78.91M |
| P3 Health Partners | 78.27M |
| Armata Pharmaceuticals | 77.79M |
| OptimizeRx | 76.82M |
| Oncolytics Biotech | 76.26M |
| ESSA Pharma | 76.09M |
| Quince Therapeutics | 75.68M |
| Aerovate Therapeutics | 75.51M |